首页> 外文会议>Conference on imaging processing >Texture Analysis For Survival Prediction of Pancreatic Ductal Adenocarcinoma Patients with Neoadjuvant Chemotherapy
【24h】

Texture Analysis For Survival Prediction of Pancreatic Ductal Adenocarcinoma Patients with Neoadjuvant Chemotherapy

机译:纹理分析对胰腺癌新辅助化疗患者生存率的预测

获取原文

摘要

Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related death in the United States. The five-year survival rate for all stages is approximately 6%, and approximately 2% when presenting with distant disease. Only 10-20% of all patients present with resectable disease, but recurrence rates are high with only 5 to 15% remaining free of disease at 5 years. At this time, we are unable to distinguish between resectable PDAC patients with occult metastatic disease from those with potentially curable disease. Early classification of these tumor types may eventually lead to changes in initial management including the use of neoadjuvant chemotherapy or radiation, or in the choice of postoperative adjuvant treatments. Texture analysis is an emerging methodology in oncologic imaging for quantitatively assessing tumor heterogeneity that could potentially aid in the stratification of these patients. The present study derives several texture-based features from CT images of PDAC patients, acquired prior to neoadjuvant chemotherapy, and analyzes their performance, individually as well as in combination, as prognostic markers. A fuzzy minimum redundancy maximum relevance method with leave-one-image-out technique is included to select discriminating features from the set of extracted features. With a naive Bayes classifier, the proposed method predicts the 5-year overall survival of PDAC patients prior to neoadjuvant therapy and achieves the best results in terms of the area under the receiver operating characteristic curve of 0.858 and accuracy of 83.0% with four-fold cross-validation techniques.
机译:胰腺导管腺癌(PDAC)是美国癌症相关死亡的第四大主要原因。所有阶段的五年生存率约为6%,如果出现远处疾病,则约为2%。在所有患者中,只有10-20%患有可切除的疾病,但是复发率很高,在5年内只有5%至15%的患者没有疾病。目前,我们无法区分具有隐匿性转移性疾病的可切除PDAC患者和具有潜在治愈性的PDAC患者。这些肿瘤类型的早期分类最终可能导致初始治疗的改变,包括新辅助化疗或放疗的使用,或术后辅助治疗的选择。质地分析是肿瘤成像中新兴的方法,用于定量评估可能有助于这些患者分层的肿瘤异质性。本研究从新辅助化疗之前获得的PDAC患者的CT图像中得出了几种基于纹理的特征,并分别分析了它们的性能以及作为预后标志物的组合。一种模糊的最小冗余度最大相关性方法,带有留一幅图像输出技术,用于从提取的特征集中选择区分特征。使用朴素的贝叶斯分类器,该方法可预测新辅助治疗之前PDAC患者的5年总生存期,并且在接收器工作特征曲线下面积为0.858和准确度为83.0%(四倍)方面达到最佳结果交叉验证技术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号